EBIT Margin: Earnings before interest and taxes as a portion of total revenues. Calculated as: EBIT / Total Revenues
Aeolus Pharmaceuticals Inc. (AOLS) had EBIT Margin of -7300.00% for the most recently reported fiscal quarter, ending 2017-06-30.
| Income Statement Financials | |
$0.01M |
|
$-0.95M |
|
-- |
|
$0.01M |
|
$0.96M |
|
$-0.95M |
|
-- |
|
$-0.95M |
|
$-0.95M |
|
$-0.95M |
|
$-0.95M |
|
$-0.95M |
|
$-0.95M |
|
$-0.95M |
|
$-0.95M |
|
152.09M |
|
152.09M |
|
$-0.01 |
|
$-0.01 |
|
| Balance Sheet Financials | |
$0.76M |
|
-- |
|
$0.03M |
|
$0.79M |
|
$0.59M |
|
-- |
|
-- |
|
$0.59M |
|
$0.21M |
|
$0.21M |
|
$0.21M |
|
152.09M |
|
| Cash Flow Statement Financials | |
$-2.75M |
|
-- |
|
-- |
|
$3.15M |
|
$0.40M |
|
$-2.75M |
|
$0.08M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.30 |
|
-- |
|
-- |
|
-- |
|
-- |
|
100.00% |
|
-7300.00% |
|
|
EBIT Margin |
-7300.00% |
-- |
|
-7300.00% |
|
-7300.00% |
|
$-2.75M |
|
-- |
|
-- |
|
-- |
|
0.02 |
|
-- |
|
0.04 |
|
2166.92 |
|
-458.45% |
|
-458.45% |
|
-119.52% |
|
-458.45% |
|
$0.00 |
|
$-0.02 |
|
$-0.02 |
|